EDAP TMS S.A., each representing One Ordinary Share (EDAP): Price and Financial Metrics


EDAP TMS S.A., each representing One Ordinary Share (EDAP)

Today's Latest Price: $4.63 USD

0.00 (0.00%)

Updated Oct 23 4:00pm

Add EDAP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

EDAP Stock Summary

  • EDAP's current price/earnings ratio is 84.23, which is higher than 90.1% of US stocks with positive earnings.
  • Price to trailing twelve month operating cash flow for EDAP is currently 36.48, higher than 89.46% of US stocks with positive operating cash flow.
  • Over the past twelve months, EDAP has reported earnings growth of 88.01%, putting it ahead of 87.25% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Edap Tms Sa, a group of peers worth examining would be DESP, AVNW, PERI, VOXX, and VIVO.
  • EDAP's SEC filings can be seen here. And to visit Edap Tms Sa's official web site, go to www.edap-tms.com.

EDAP Stock Price Chart Interactive Chart >

Price chart for EDAP

EDAP Price/Volume Stats

Current price $4.63 52-week high $5.39
Prev. close $4.64 52-week low $1.46
Day low $4.60 Volume 68,900
Day high $4.93 Avg. volume 109,883
50-day MA $4.11 Dividend yield N/A
200-day MA $3.21 Market Cap 134.26M

EDAP TMS S.A., each representing One Ordinary Share (EDAP) Company Bio


EDAP TMS S.A. develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases worldwide. The company was founded in 1979 and is based in Vaulx-en-Velin, France.

EDAP Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$4.63$2.55 -46%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Edap Tms Sa. To summarize, we found that Edap Tms Sa ranked in the 32th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. The most interesting components of our discounted cash flow analysis for Edap Tms Sa ended up being:

  • As a business, EDAP is generating more cash flow than merely 8.09% of positive cash flow stocks in the Healthcare.
  • The business' balance sheet reveals debt to be 6% of the company's capital (with equity being the remaining amount). Approximately merely 16.85% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • EDAP's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 42.39% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-47%
1%-47%
2%-46%
3%-46%
4%-45%
5%-45%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as EDAP, try OSMT, GILD, IQV, MD, and QDEL.


EDAP Latest News Stream


Event/Time News Detail
Loading, please wait...

EDAP Latest Social Stream


Loading social stream, please wait...

View Full EDAP Social Stream

Latest EDAP News From Around the Web

Below are the latest news stories about Edap Tms Sa that investors may wish to consider to help them evaluate EDAP as an investment opportunity.

EDAP Set For Long-Term Growth

EDAP (EDAP) is surviving the drought of hospitals buying new stuff as a result of the pandemic being quite a bit better than many would have thought, which is why their share price has recovered nicely after encouraging Q2 results: We wrote in October last year that the company was...

Shareholders Unite on Seeking Alpha | September 16, 2020

EDAP TMS (EDAP) Catches Eye: Stock Jumps 7.4%

EDAP TMS (EDAP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Yahoo | July 20, 2020

EDAP TMS up 31% on Focal One sales progress

Thinly traded nano cap EDAP TMS SA ([[EDAP]] +30.9%) is up a 9x surge in volume on the heels of its update on recent sales of its Focal One HIFU device.In Q2, Lyon, France-based Edouard Herriot University Hospital and Ochsner Medical Center in New Orleans, LA signed on. Both sales...

Seeking Alpha | July 15, 2020

EDAP Announces Recent Focal One Sales Successes

Company completes four Focal One sales, including three bundled sales that combine Focal One® with Exact Imaging’s ExactVu micro ultrasound imaging solutionCompany recorded an.

Yahoo | July 15, 2020

Edited Transcript of EDAP earnings conference call or presentation 14-May-20 12:30pm GMT

Q1 2020 Edap Tms SA Earnings Call

Yahoo | July 8, 2020

Read More 'EDAP' Stories Here

EDAP Price Returns

1-mo 15.75%
3-mo 42.46%
6-mo 95.36%
1-year -7.77%
3-year 54.33%
5-year -0.86%
YTD 4.51%
2019 139.46%
2018 -35.54%
2017 -12.50%
2016 -20.58%
2015 77.25%

Continue Researching EDAP

Here are a few links from around the web to help you further your research on Edap Tms Sa's stock as an investment opportunity:

Edap Tms Sa (EDAP) Stock Price | Nasdaq
Edap Tms Sa (EDAP) Stock Quote, History and News - Yahoo Finance
Edap Tms Sa (EDAP) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8062 seconds.